Johnson & Johnson gets $115 million cash injection for ebola vaccine

January 16, 2015 5:57 PM

12 0

Johnson & Johnson said a partnership of the public-private sector in Europe has allocated 100 million euro, or about $115 million, to boost its Ebola vaccine project. The company already has the vaccine in an early stage trial on humans. The drug showed positive results in terms of efficacy and safety in a trial on monkeys.

The cash boost will help the company in conducting clinical trials, production and creating awareness about the vaccine. Johnson & Johnson intends to initiate Phase 2 and Phase 3 trials of the drug in Africa and Europe. The company will receive the grant through its consortia that include institutio...

Also read: PayPal Agrees to Buy Payments Firm Hyperwallet for $400 Million

Read more

To category page